ArticleInternational journal of clinical oncology2017

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.

Hiroki Ishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.